Abstract
Danish healthcare seeks to improve cancer survival through improved diagnostics, rapid treatment and increased focus on cancer prevention and early help-seeking. In neuro-oncology, this has resulted in the Integrated Brain Cancer Pathway (IBCP). The paper explores how the pathway works in the initial phase in a clinical setting with emphasis on pathway criteria.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Danish Medical Journal |
Vol/bind | 59 |
Udgave nummer | 5 |
Sider (fra-til) | A4437 |
Status | Udgivet - 2012 |